Christian Bourne

Christian is a family man from the North West of England. Originally from Liverpool, he has lived on the Wirral for many years. As you can see the “sunset” side of the island provides a fantastic quality of life combined with excellent transport links that allows Christian to work anywhere in the world from a great base.

As an experienced wet lab scientist utilising all NGS platforms, Christian transferred hands-on experience, skills, and knowledge to competitive market and business development roles, driving the adoption of technologies within clinical, research, and academic-focused programmes.

Instrumental in the design & implementation of the clinically accredited end-to-end sequencing workflow for the Genomics England 100k project, Christian has continuously built & improved on this unique experience to provide best-in-class consulting services. Services, which include end-to-end, bedside-to-bedside project & programme design, onsite gap analysis & detailed reporting driving timelines for readiness & subsequent implementation, verification & validation planning to allow for accurate, real-world & KPI design.

This knowledge & experience have afforded Christian the opportunity to positively impact over thirty ultra-high throughput, global population scale genomics & clinical testing programmes, including:

  • Genomics England Rare Disease 2.0, including assisting in creating the ISO:15189(2022) service lab.

  • The PRECISE programme in Singapore, consulting on both the short read 100k & long read Phase II.

  • NIHR 22k project focusing on Rare Disease, Eating Disorders Genetics Initiative (EDGI) UK cohort & the Genes & Cognition Study across multiple sequencing facilities in Cambridge & King’s College London.

  • Biomedical Genome-Based Science Initiative of Indonesian MoH (BGS-i), incorporating the five initial contributing clinical sites across Indonesia.

  • 100k Caribbean Genome Project.

  • Leading UK genomic initiatives including UK Biobank & DecodeME.

  • Global genomic initiatives, including Thailand, Hong Kong, Japan, Korea, Qatar: WWRC, Abu Dhabi: MBRU & Life Core, including their CLIA accreditation, Dubai, Columbia, Bahrain, South Africa, Estonia, and Kazakhstan.

While working with industry-leading biotech organisations, Christian maintained a technologically agnostic approach to interactions & guidance, believing it a duty to enable multiomics to benefit patients, programmes, academia, research & public alike. This desire to provide a technology-neutral interaction with clients drives Christian to provide advice suited to stakeholder requirements to enable the best project success & meaningful outcomes for patients &/or participants.

Christian successfully engages at all levels of large-scale clinical and research multi-omics programmes, including MoH, PIs and key stakeholders, focus/public engagement groups, and medical multi-disciplinary teams (MDTs), as well as the end users.

We believe in managing multi-disciplinary teams (MDT), developing KOL relationships & facilitating partnership engagements at the genomics, research & industry interface, with a proven track record of leading & delivering global, cross-functional programmes across business units, government(s), healthcare providers, private bodies & industries within & across countries & timezones allows Christian to be uniquely placed to assist with your multiomics programme requirements.

Please feel free to contact us to have an initial conversation with Christian to assess your requirements and needs.